New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
13:49 EDTWORWorthington CEO expects Q4 to 'yield a solid performance'
CEO John McConnell said, "We anticipate the fourth quarter, historically our strongest, to yield a solid performance to finish out our fiscal year. We will continue to pursue our strategy of growth with our existing businesses as well as through acquisition opportunities in growing markets."
News For WOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2015
09:05 EDTWOROn The Fly: Pre-market Movers
HIGHER: Arrowhead Research (ARWR), up 35% after disclosing top-line findings from the Heparc-2001 Phase 2a clinical study of ARC-520, its candidate for the treatment of chronic hepatitis B infection... Conatus Pharmaceuticals (CNAT), up 19% after the company's Phase 2 Portal Hypertension clinical trial of emricasan met its primary endpoints... Keryx Biopharmaceuticals (KERX), up 13% after announcing that the European Commission has approved Fexeric for the control of elevated serum phosphorus levels, or hyperphosphatemia, in adults with chronic kidney disease. LOWER: Caterpillar (CAT), down 5% after announcing restructuring plans, lowering revenue guidance, and having stock initiated with a Sell rating and a $28 price target at Axiom... Twitter (TWTR), down 1.5% after Citi cut estimates below consensus and lowered its price target to $30. DOWN AFTER EARNINGS: Worthington (WOR), down 12.5%... Accenture (ACN), down 3%.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use